PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+25.01%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.53B
AUM Growth
+$1.53B
(+23%)
Cap. Flow
+$73.9M
Cap. Flow
% of AUM
4.82%
Top 10 Holdings %
Top 10 Hldgs %
51.28%
Holding
202
New
46
Increased
42
Reduced
36
Closed
32
Top Buys
| 1 |
RXDX
Ignyta, Inc.
RXDX
|
$29.7M |
| 2 |
Sarepta Therapeutics
SRPT
|
$18.4M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$17.9M |
| 4 |
Viatris
VTRS
|
$14.3M |
| 5 |
Heron Therapeutics
HRTX
|
$14M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$21.8M |
| 2 |
BLUE
bluebird bio
BLUE
|
$16.3M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$11.1M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$11M |
| 5 |
uniQure
QURE
|
$10.5M |
Sector Composition
| 1 | Healthcare | 83.91% |
| 2 | Financials | 0.1% |
| 3 | Technology | 0.06% |
| 4 | Consumer Discretionary | 0.06% |
| 5 | Energy | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Assembly Biosciences
ASMB
$183M
| $15.1M | 0.91% |
784,893
+359,893
| +85% | +$6.93M |
|
27
Zimmer Biomet
ZBH
$20.8B
| $14.8M | 0.89% |
135,193
-45,600
| -25% | -$4.98M |
|
|
28
Viatris
VTRS
$12.3B
| $14.6M | 0.88% |
215,133
+210,000
| +4,091% | +$14.3M |
|
|
29
Heron Therapeutics
HRTX
$204M
| $14M | 0.84% |
+448,000
| New | +$14M |
|
|
AFMD
30
DELISTED
Affimed
AFMD
| $13.8M | 0.83% |
1,023,820
+218,000
| +27% | +$2.94M |
|
|
CASC
31
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $12.5M | 0.75% |
3,346,897
+2,421,897
| +262% | +$9.06M |
|
|
BLCM
32
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $11.8M | 0.71% |
552,628
-493,774
| -47% | -$10.5M |
|
|
RCPT
33
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $11.6M | 0.7% |
60,969
-57,825
| -49% | -$11M |
|
|
BPMC
34
DELISTED
Blueprint Medicines
BPMC
| $10.7M | 0.65% |
+404,404
| New | +$10.7M |
|
|
ANTH
35
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $10.4M | 0.62% |
1,202,156
-401,000
| -25% | -$3.46M |
|
|
ADYX
36
DELISTED
Adynxx, Inc. Common Stock
ADYX
| $10.1M | 0.61% |
1,921,951
+800,000
| +71% | +$4.22M |
|
|
THOR
37
DELISTED
THORATEC CORPORATION
THOR
| $10.1M | 0.61% |
226,000
-74,000
| -25% | -$3.3M |
|
|
SHPG
38
DELISTED
Shire pic
SHPG
| $9.66M | 0.58% |
40,000
+10,000
| +33% | +$2.42M |
|
39
Sangamo Therapeutics
SGMO
$161M
| $8.87M | 0.53% |
800,000
| – | – |
|
|
XLRN
40
DELISTED
Acceleron Pharma Inc.
XLRN
| $8.73M | 0.53% |
276,036
-60,000
| -18% | -$1.9M |
|
|
NEPT
41
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $8.64M | 0.52% |
6,700,444
-50,000
| -0.7% | -$65K |
|
|
QTNT
42
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $8.58M | 0.52% |
562,436
+11,566
| +2% | +$176K |
|
|
OTIC
43
DELISTED
Otonomy, Inc.
OTIC
| $8.45M | 0.51% |
367,386
-113,001
| -24% | -$2.6M |
|
44
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $7.48M | 0.45% |
258,716
+173,428
| +203% | +$5.01M |
|
45
BioCryst Pharmaceuticals
BCRX
$1.74B
| $7.02M | 0.42% |
+470,000
| New | +$7.02M |
|
46
Insmed
INSM
$30.3B
| $6.98M | 0.42% |
285,812
-300,000
| -51% | -$7.33M |
|
|
VBIV
47
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $6.81M | 0.41% |
2,610,365
+9
| +0% | – |
|
48
Aldeyra Therapeutics
ALDX
$350M
| $6.75M | 0.41% |
869,800
+512,800
| +144% | +$3.98M |
|
|
CLLS
49
Cellectis
CLLS
$260M
| $6.55M | 0.39% |
181,500
+180,000
| +12,000% | +$6.49M |
|
50
Eledon Pharmaceuticals
ELDN
$155M
| $6.46M | 0.39% |
485,338
+27,000
| +6% | +$360K |
|